Maligne Erkrankungen bei Kindern und Jugendlichen

  • B. Kremens
  • W. Havers

Zusammenfassung

Leukämien und maligne Tumoren sind im Kindesalter seltene Erkrankungen. Das Kindertumorregister der Deutschen Gesellschaft für Pädiatrische Hämatologie und Onkologie an der Universität Mainz gibt die Inzidenz für die letzten 7 Jahre konstant mit 13–14 Neuerkrankungenhoo 00o Kinder unter 15 Jahren an (Haaf et al. 1993). Das Risiko eines Kindes, vor seinem 15. Geburtstag an einem Malignom zu erkranken, beträgt 0,2%. Trotz der eindrucksvollen Therapieerfolge der Kinderonkologie in den letzten beiden Jahrzehnten sind Krebserkrankungen die nach Unfällen zweithäufigste Todesursache bei Kindern jenseits des Säuglingsalters.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Arneil GC, Harris F, Emmanuel JG, Young DG, Flatman GE, Zachary RB (1974) Nephritis in two children after irradiation and chemotherapy for nephroblastoma. Lancet I: 960–963Google Scholar
  2. Berthold F, Brandeis WE, Lampert F (1986) Neuroblastoma: diagnostic advances and therapeutic results in 37o patients. Monogr Paediatr 18: 206–223Google Scholar
  3. Berthold F, Burdach S, Kremens B et al. (1990) The role of chemotherapy in the treatment of children with neuroblastoma stage IV: the GPO (German Paediatric Oncology Society) experience. Klin Pädiatr 202: 262–269PubMedGoogle Scholar
  4. Berthold F, Trechow R, Utsch S, Zierschang J (1992) Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 14: 207–215PubMedGoogle Scholar
  5. Bielack SS, Beck JD, Winkler K (1995) Spätfolgen nach Krebsbehandlung im Kindesalter. Monatsschr Kinderheilkd 143: 649–657Google Scholar
  6. Bjorkholm E, Lundell M, Gyftodimos A (1990) Dysgerminoma: the Radiumhemmet series 1927–1984. Cancer 65: 38–44PubMedGoogle Scholar
  7. Bloom HJG (1983) Primary intracranial germ cell tumors. Clin Oncol 2: 233–257Google Scholar
  8. Bloom HJG, Glees J, Bell J (1990) The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950–1981. Int J Radiat Oncol Biol Phys 18: 723–745PubMedGoogle Scholar
  9. Brämswig JH, Wegele M, von Lengerke HJ, Müller RP, Schellong G (1989) The effect of the number of fractions of cranial irradiation on growth in children with acute lymphoblastic leukaemia. Acta Paediatr Scand 78: 296–302PubMedGoogle Scholar
  10. Brochstein JA, Kernan NA, Groshen S et al. (1987) Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 317: 1618–1624PubMedGoogle Scholar
  11. Brodeur GM, Pritchard J, Berthold F et al. (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466–1477PubMedGoogle Scholar
  12. Brouwers P, Poplack D (1990) Memory and learning sequelae in longterm survivors of acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 12: 174–181PubMedGoogle Scholar
  13. Burdach S, Jürgens H, Peters C et al. (1993) Myeloablative radiotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing’s sarcoma. J Clin Oncol 11: 1482–1488PubMedGoogle Scholar
  14. Cheung NKV, von Hoff D, Strandjord S, Coccia PF (1986) Detection of neuroblastoma cells in bone marrow using GD2 spedific monoclonal antibodies. J Clin Oncol 4: 363–369PubMedGoogle Scholar
  15. Cheung NKV, Burch L, Kushner BH, Munn DH (1991) Monoclonal antibody 3 F 8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial. Prog Clin Biol Res 366: 395-400PubMedGoogle Scholar
  16. Christiansen H, Schestag J, Christiansen NM, Grzeschik KH, Lampert F (1992) Clinical impact of chromosome I aberrations in neuroblastoma: a metaphase and interphase cytogenetic study. Genes Chromosom Cancer 5: 141–149PubMedGoogle Scholar
  17. Constine LS, Donaldson SS, McDougall R, Cox RS, Link MP, Kaplan HS (1984) Thyroid dysfunction after radiotherapy in children with Hodgkin’s disease. Cancer 53: 878–883PubMedGoogle Scholar
  18. Corn BW, Trock GJ, Goodman RL (1990) Irradiation-related ischemic heart disease. J Clin Oncol 8: 741–750PubMedGoogle Scholar
  19. Creutzig U, Ritter J, Zimmermann M, Schellong G (1993) Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia: unexpected results of the childhood acute myelogenous leukemia study BFM-87. J Clin Oncol 11: 279–286PubMedGoogle Scholar
  20. D’Angio GJ, Breslow N, Beckwith JB et al. (1989) Treatment of Wilms’s tumor. Results of the third National Wilms’ Tumor Study. Cancer 64: 349PubMedGoogle Scholar
  21. Delattre O, Zucman J, Melot T et al. (1994) The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331: 294–299PubMedGoogle Scholar
  22. Donaldson SS, Jundt S, Ricour C, Sarrazin D, Lemerle J, Schweisguth O (1975) Radiation enteritis in children: a retrospective review, clinicopathologic correlation, and dietary management. Cancer 35: 1167–1178PubMedGoogle Scholar
  23. Dopfer R, Henze G, Bender-Götze C et al. (1991) Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-Protocols: results of the German Cooperative Study. Blood 78: 2780–2784PubMedGoogle Scholar
  24. Duffner PK, Cohen ME (1992) Changes in the approach to central nervous system tumors in childhood. Pediatr Clin North Am 39: 859–877PubMedGoogle Scholar
  25. Duffner PK, Horowitz ME, Krischer JP et al. (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328: 1725–1731PubMedGoogle Scholar
  26. Dunst J, Sauer R, Burgers JMV et al. (1991) Radiation therapy as local treatment in Ewing’s sarcoma. Results of the Cooperation Ewing Sarcoma Studies CESS 81 and 86. Cancer 67: 2818–2825PubMedGoogle Scholar
  27. Eng C, Li FP, Abramson DH et al. (1993) Mortality from second tumors among long-term survivors of retino-blastoma. J Natl Cancer Inst 85: 1121PubMedGoogle Scholar
  28. Evans AE, Jenkin RDT, Sposto R et al. (1990) The results of a prospective randomised trial of radiation therapy with and without CCNU, vincristine and prednisolone. J Neurosurg 72: 572–582PubMedGoogle Scholar
  29. Ewing J (1921) Diffuse endothelioma of bone. Proc NY Pathol Soc 21: 17–20Google Scholar
  30. Farwell JR, Dohrmann GJ, Flannery JT (1984) Medulloblastoma in childhood: an epidemiologic study. J Neurosurg 61: 657–664PubMedGoogle Scholar
  31. Favara BE (1991) Langerhans cell histiocytosis. Pathobiology and pathogenetis. Semin Oncol 18: 3–7PubMedGoogle Scholar
  32. Favrot M, Floret D, Michon J et al. (1989) A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 cases. Cancer Treat Rev 16: 129–142PubMedGoogle Scholar
  33. Finch SC (1984) Leukemia and lymphoma in abonic bomb survivors. In: Boice JD, Franmeni JF (eds) Radiation carcinogenesis: epidemiology and biological significance. Raven, New York, pp 37–44Google Scholar
  34. Finklestein JZ, Krailo MD, Lenarsky C et al. (1992) 13-cisRetinoic Acid (NCS 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group. Med Pediatr Oncol 20: 307–311PubMedGoogle Scholar
  35. Freeman JE, Johnston PGB, Voke JM (1973) Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukemia. BMJ 4: 523–526PubMedGoogle Scholar
  36. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP (1990) Homozygous deletion in Wilms’ tumour of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778PubMedGoogle Scholar
  37. Glauser TA, Packer R (1991) Cognitive deficits in long-term survivors of childhood brain tumors. Childs Nery Syst 7: 2–12Google Scholar
  38. Göbel U, Bamberg M, Calaminus G et al. (1993a) Verbesserte Prognose intracranialer Keimzelltumoren durch intensivierte Therapie: Ergebnisse des Therapieprotokolls MAKEI 89. Klin Pädiatr 205: 217–224Google Scholar
  39. Göbel U, Calaminus G, Teske C et al. (1993b) BEP/VIP bei Kindern und Jugendlichen mit malignen nichttestikulären Keimzelltumoren. Klin Pädiatr 205: 231–240Google Scholar
  40. Gonzales D, Breur K (1983) Clinical data from irradiated growing long bones in children. Int J Radiat Oncol Biol Phys 9: 841–846Google Scholar
  41. Green AA, Hustu HO, Palmer R, Pinkel D (1976) Total-body sequential irradiation and combination chemotherapy for children with disseminated neuroblastoma. Cancer 38: 2250–2257PubMedGoogle Scholar
  42. Green DM, D’Angio GJ, Beckwith JB, Breslow NE, Finkle-stein JZ, Kelalis P, Thomas PRM (1993) Wilms’ tumor (nephroblastoma, renal embryoma). In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott, Philadelphia, pp 713–737Google Scholar
  43. Gutjahr P (1993) Sekundärmalignome nach Krebserkrankungen bei Kindern. Dtsch Arztebl 90: 1593–1604Google Scholar
  44. Gutjahr P, Schwenger M, Spaar HJ et al. (1990) Bedeutung der präoperativen Chemotherapie und der Radiotherapie bei 373 Kindern mit Wilms-Tumor. Dtsch Med Wochenschr 115: 248PubMedGoogle Scholar
  45. Haaf HG, Kaatsch P, Michaelis J (1993) Jahresbericht des Deutschen Kinderkrebsregisters, MainzGoogle Scholar
  46. Halperin EC, Cox EB (1986) Radiation therapy in the management of neuroblastoma. The Duke University Medical Center Experience 1967–1984. Int J Radiat Oncol Biol Phys 12: 1829PubMedGoogle Scholar
  47. Halperin EC, Kun LE, Constine LS, Tarbell NJ (1989) Pediatric radiation oncology: late effects of cancer treatment. Raven, New York, pp 344–386Google Scholar
  48. Hansen MF, Konfos A, Gallie BL et al. (1985) Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 82: 6216–6220PubMedGoogle Scholar
  49. Hauffa BP, Liebers E, Bornfeld N, Sauerwein W, Havers W (1995) Wachstum und Entwicklung von Kindern und Jugendlichen mit Retinoblastom nach operativer Therapie, Strahlentherapie und Chemotherapie. Monatsschr Kinderheilkd 143: 1091–1098Google Scholar
  50. Havers W, Stollmann B, Bachmann HJ, Bamberg M, Stambolid C (1980) Bestrahlungsbedingte Nierenerkrankung nach Behandlung von Malignomen im Kindesalter. Onkologie 3: 58–62PubMedGoogle Scholar
  51. Havers W, Alberti W, Messmer EP, Rath B, Höpping W (1986) Retinoblastoma. In: Riehm H (ed) Malignant neoplasias in childhood and adolescence. Monogr Paediatr 18: 342–358Google Scholar
  52. Hawkins MM, Droper GJ, Kingston JE (1987) Incidence of second primary tumors among childhood cancer survivors. Br J Cancer 56: 339–347PubMedGoogle Scholar
  53. Henze G, Langermann HJ, Brämswig J et al. (1981) Ergebnisse der Studie BFM 76/79 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen. Klin Pädiatr 193: 145–157PubMedGoogle Scholar
  54. Henze G, Fengler R, Hartmann R (1994) Chemotherapy for relapsed childhood acute lymphoblastic leukemia: results of the BFM Study Group. Haematol Blood Transfus 36: 374–379Google Scholar
  55. Hoppe-Hirsch E, Renier D, Lellouch-Tubiana A, Sainte-Rose C, Piere-Kahn A, Hirsch JF (1990) Medulloblastoma in childhood: progressive intellectual deterioration. Childs Nerv Syst 6: 60–65PubMedGoogle Scholar
  56. Höpping W, Havers W, Passarge E (1990) Retinoblastom. In: Bachmann KD, Ewerbeck H, Kleihauer E et al. (Hrsg) Pädiatrie in Praxis und Klinik. Fischer und Thieme, Stuttgart, S 755–770Google Scholar
  57. Hudson MM, Greenwald C, Ghompson E et al. (1993) Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin’s disease. J Clin Oncol 11: l00–108Google Scholar
  58. Hurwitz CA, Mounce KG, Grier HE (1995) Treatment of patients with acute myelogenous leukemia: review of clinical trials of the past decade. J Pediatr Hematol Onco117: 185–197Google Scholar
  59. Ingold JA, Reed GB, Kaplan HS, Bagshaw MA (1963) Radiation hepatitis. Am J Roentgenol 93: 200–208Google Scholar
  60. Jacobson HM, Marcus RB, Thar TL, Million RR, Graham-Pole JR, Thalberg JL (1983) Pediatric neuroblastoma: postoperative radiation therapy using less than 2000 rad. Int J Radiat Oncol Biol Phys 9: 501–505PubMedGoogle Scholar
  61. Jaffe N, Filler RM, Farber S, Graggis DG, Vawter FF, Tefft M, Murray JE (1973) Rhabdomyosarcoma in children-improved outlook with a multidisciplinary approach. Am J Surg 125: 482–487PubMedGoogle Scholar
  62. Jaffe N, Graggis D, Salian S, Cassacy JR (1976) Improved outlook for Ewing’s sarcoma with combination chemotherapy (Vincristin, Actinomycin D, and Cyclophosphamide) and radiation therapy. Cancer 38: 1925–1930PubMedGoogle Scholar
  63. Jennings MT, Gehman R, Hochberg F (1985) Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg 63: 155–167PubMedGoogle Scholar
  64. Jürgens H, Exner U, Gadner H et al. (1988a) Multidisciplinary treatment of primary Ewing’s sarcoma od bone. Cancer 61: 23–32Google Scholar
  65. Jürgens H, Bier V, Harms D et al. (1988b) Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients. Cancer 61: 349-357Google Scholar
  66. Kaatsch P, Michaelis J (1995) Zweitmalignome nach malignen Erkrankungen im Kindesalter. Klin Pädiatr 207: 158–163PubMedGoogle Scholar
  67. Kingston JE, Hungerford JL, Plowman PN (1987) Chemotherapy in metastatic retinoblastoma. Ophthal Paediat Gen 8: 69Google Scholar
  68. Klingebiel T, Berthold F, Treuner J et al. (1991) Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the german neuroblastoma trial. Med Pediatr Oncol 19: 84–88PubMedGoogle Scholar
  69. Koscielniak E, Jürgens H, Winkler K et al. (1992) Treatment of soft tissue sarcoma in childhood and adolescence. Cancer 7o: 2557-2567Google Scholar
  70. Koscielniak E, Herbst M, Niethammer D, Treuner J (1994) Verbesserung durch einen frühen and risikoadaptierten Einsatz der Radiotherapie bei primär nicht resektablem Rhabdomyosarkomen: Ergebnisse der CWS 81 and 86 Studien. Klin Pädiatr 206: 269–276PubMedGoogle Scholar
  71. Kremens B, Sadony W, Goepel M, Hellinger A, Havers W (1991) Management of nephroblastoma with intracardiac extension: three case reports and review of the literature. Pediatr Hematol Oncol 8: 335-345PubMedGoogle Scholar
  72. Kremens B, Klingebiel T, Hermann F et al. (1994) High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastoma. Med Pediatr Oncol 23: 470–475PubMedGoogle Scholar
  73. Kühl J, Beck J, Bode U et al. (1995) Delayed radiation therapy (RT) after postoperative chemotherapy (PCH) in children less than 3 years of age with medulloblastoma. Results of the trial HIT-SKK 87, and preliminary results of the pilot trial HIT-SKK 92. Med Pediatr Oncol 25: 250Google Scholar
  74. Ladenstein R, Hartmann 0, Pinkerton R (1993) The role of megatherapy with autologous bone marrow rescue in solid tumors of childhood. Ann Oncol 4: 45–58PubMedGoogle Scholar
  75. Leiper AD, Grant GB, Chessels JM (1983) The effect of testicular irradiation on Leydig cell function in prepubertal boys with acute lymphoblastic leukemia. Arch Dis Child 58: 906–910PubMedGoogle Scholar
  76. Lewin K, Mills RR (1973) Human radiation hepatitis: a morphologic study with emphasis on the late changes. Arch Pathol 96: 21–26PubMedGoogle Scholar
  77. Ludwig R, Weirich A, Pötter R et al. (1992) Präoperative Chemotherapie des Nephroblastoms. Vorläufige Ergebnisse der Therapiestudie SIOP-9/GPO. Klin Pädiatr 204: 204–213PubMedGoogle Scholar
  78. Luxton RW, Kunkler PB (1964) Radiation nephritis. Acta Radiol 2: 169–178Google Scholar
  79. Mahour GH, Soule EH, Mills SD, Lynn HB (1976) Rhabdomyosarcoma in infants and children: a clinicophatologic study of 75 cases. J Pediatr Surg 2: 402–409Google Scholar
  80. Marcove RC, Mik¨¦ V, Hajek JV, Levin AG, Hutter RVP (1970) Osteogenic sarcoma under the age of twenty-one. A review of 145 operative cases. J Bone Joint Surg Am 52: 411–423PubMedGoogle Scholar
  81. Molls M, Stuschke M (1991) Radiotherapy in childhood: normal tissue injuries and carcinogenesis. In: Scherer E, Streffer C, Trott KR (eds) Radiopathology of organs and tissues. Springer, Berlin Heidelberg New York Tokyo, pp 461–477 (Medical radiology series)Google Scholar
  82. Nesbit ME, Krivit W (1975) Histiocytosis. In: Bloom HJG, Lemerle J, Neidhardt MK, Voûte PA (eds) Cancer in children. Springer, Berlin Heidelberg New York, pp 193–199Google Scholar
  83. Oberlin O, Leverger G, Pacquement H et al. (1992) Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin’s disease: the experience of the French Society of Pediatric Oncology. J Clin Oncol 10: 1602–1608PubMedGoogle Scholar
  84. Ortin TTS, Shostak CA, Donaldson SS (1990) Gonadal status and reproductive function following treatment for Hodgkin’s disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys 19: 873–880PubMedGoogle Scholar
  85. Packer RJ, Sutton LN, Goldwein JW et al. (1991) Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74: 433–440PubMedGoogle Scholar
  86. Philip T, Zucker JM, Bernard JL et al. (1991) Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? J Clin Oncol 9: 1037–1044PubMedGoogle Scholar
  87. Phillips TL, Fu KK (1978) The interaction of drug and radiation effects on normal tissues. Int J Radiat Oncol Biol Phys 4: 59–64PubMedGoogle Scholar
  88. Phillips TL, Margolis L (1972) Radiation pathology and the clinical response of lung and esophagus. In: Vaeth JM (ed) Frontiers of therapy and oncology. Baltimore University Park Press, pp 254–273Google Scholar
  89. Plowman PN (1983) The effects of conventionally fractionated, exthuded portal radiotherapy on the human peripheral blood count. Int J Radiat Oncol Biol Phys 9: 829–839PubMedGoogle Scholar
  90. Price RA, Jamieson PA (1975) The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 35: 306–318PubMedGoogle Scholar
  91. Raney RB, Hays DM, Lawrence W, Soule EH, Tefft M, Donaldson MH (1978) Paratesticular rhabdomyosarcoma in childhood. Cancer 42: 729–736PubMedGoogle Scholar
  92. Rappaport R, Brauner R (1989) Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res 25: 561–567PubMedGoogle Scholar
  93. Reiter A, Schrappe M, Ludwig WD et al. (1994a) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84: 3122–3133Google Scholar
  94. Reiter A, Schrappe M, Yasisan E et al. (1994b) Therapiestudie NHL-BFM 90 zur Behandlung maligner Non-HodgkinLymphome bei Kindern and Jugendlichen. Eine Zwischenanalyse der Therapiegruppe B-NHL/B-ALL. Klin Pädiatr 206: 242–252Google Scholar
  95. Reiter A, Tiemann M, Ludwig WD et al. (1994c) Therapiestudie NHL-BFM 90 zur Behandlung maligner Non-HodgkinLymphome bei Kindern and Jugendlichen. Klin Pädiatr 206: 222–233Google Scholar
  96. Riehm H, Gadner H, Henze G et al. (1990) Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transfus 33: 439–450PubMedGoogle Scholar
  97. Riseborough EJ, Grabias SL, Burton RI, Jaffe N (1976) Skeletal alterations following irradiation for Wilms’ tumor, with particular reference to scoliosis and kyphosis. J Bone Joint Surg Am 58: 526–536PubMedGoogle Scholar
  98. Rosen G, Murphy ML, Huvos AG, Gutierrez M, Marcove RC (1976) Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 37: 1–11PubMedGoogle Scholar
  99. Rosen G, Kosloff C, Lane J, Murphy ML (1981) Ewing’s sarcoma: ten year experience with adjuvant chemotherapy. Cancer 47: 2204–2213PubMedGoogle Scholar
  100. Rubin P, Casarett GW (1969) Clinical radiation pathology, vol I & II. Saunders, PhiladelphiaGoogle Scholar
  101. Rubin P, Shapiro DL, Finkelstein JN, Ponney DP (1980) The early release of surfactant following lung irradiation of alveolar type II cells. Int J Radiat Oncol Biol Phys 6: 75–77PubMedGoogle Scholar
  102. Scarantino C, Rubin P, Constine L (1984) The paradoxes in patterns and mechanisms of bone marrow regeneration after irradiation. I. Different volumes and doses. Radiother Onco1 2: 215–225Google Scholar
  103. Schellong G, Lietzke S, Strauch S, Kuhne B, Schneider B (1986) Bedeutung sonographischer, computertomographischer und klinischer Befunde für die Erkennung eines Abdominalbefalls beim Morbus Hodgkin im Kindesalter - Eine retrospektive statistische Analyse bei 145 Patienten der Therapiestudie DAL-HD-82. Klin Pädiatr 198: 147–154PubMedGoogle Scholar
  104. Schellong G, Hörnig-Franz I, Rath B et al. (1994) Reduzierung der Strahlendosen auf zo-3o Gy im Rahmen einer kombinierten Chemo-/Radiotherapie beim Morbus Hodgkin im Kindesalter - Ein Berich der kooperativen Therapiestudie DAL-HD-87. Klin Pädiatr 206: 253–262PubMedGoogle Scholar
  105. Schmidt D, Harms D (1983) Histologie und Prognose des Nephroblastoms unter Berücksichtigung der Sondervarianten. Klin Pädiatr 195: 214–221PubMedGoogle Scholar
  106. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111–1116PubMedGoogle Scholar
  107. Shank B (1994) Radiotherapeutic principles of bone marrow transplantation. In: Forman S, Blume KG, Thomas ED (eds) Bone marrow transplantation. Blackwell, Boston, pp 96–113Google Scholar
  108. Silber JH, Radcliffe J, Peckham W et al. (1992) Whole brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J Clin Oncol 1o: 1390–1396Google Scholar
  109. Stiller CA, Bunch KJ (1992) Brain and spinal tumours in children aged under two years: incidence and survival in Britain, 1971–1985. Br J Cancer 66: 50–53Google Scholar
  110. Stillmann RJ, Schingfeld JS, Schiff I (1981) Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 139: 62–66Google Scholar
  111. Sutow WW, Sullivan MR, Ried HL, Taylor HG, Griffith KM (1970) Prognosis in childhood rhabdomyosarcoma. Cancer 25: 1384–1390PubMedGoogle Scholar
  112. Tait DM, Thornton-Jones H, Bloom HJG, Lemerle J, Morris-Jones P (1990) Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26: 464–469PubMedGoogle Scholar
  113. Tarbell N, Guinan E, Niemeyer C, Nauch P, Sallan S, Weinstein H (1988) Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 15: 99–104PubMedGoogle Scholar
  114. Tefft M, Mitus A, Das L, Vowter GF, Filler RM (1970) Irradiation of the liver in children: review of experience in the acute and chronic phases, and in the intact normal and partially resected. Am J Roentgenol 108: 365–385Google Scholar
  115. Thachil JV, Jewett MAS, Rider WD (1981) The effects of cancer and cancer therapy on male fertility. J Urol 126: 141–145PubMedGoogle Scholar
  116. Treuner J, Kaatsch P, Anger Y et al. (1986) Ergebnisse bei der Behandlung von Rhabdomyosarkomen bei Kindern. Ein Bericht der Cooperativen Weichteilsarkomstudie (CWS-81). Klin Pädiatr 198: 208–217PubMedGoogle Scholar
  117. Tucker MA, Meadows AT, Boice JD (1987) Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 78: 459–464PubMedGoogle Scholar
  118. White L (1991) Chemotherapy in retinoblastoma: current status and future directions. Am J Pediatr Hematol Oncol 13: 189PubMedGoogle Scholar
  119. Williams JM, Davis KS (1986) Central nervous system prophylactic treatment for childhood leukemia: neuropsychological outcome studies. Cancer Treat Rev 13: 113–127PubMedGoogle Scholar
  120. Winkler K, Bieling P, Bielack S et al. (1991) Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry. Clin Orthopaed 270: 79–86Google Scholar
  121. Woodard HQ, Coley BL (1947) The correlation of tissue dose and clinical response in irradiation of bone tumors and of normal bone. Am J Roentgenol 57: 464–471Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • B. Kremens
  • W. Havers

There are no affiliations available

Personalised recommendations